These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7869480)

  • 21. What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis.
    Elhanbly S; Schoor R; Elmogy M; Ross L; Hegazy A; Niederberger C
    J Urol; 2002 Jan; 167(1):192-6. PubMed ID: 11743303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitation of corporeal venous outflow resistance in man by corporeal pressure flow evaluation.
    Freidenberg DH; Berger RE; Chew DE; Ireton R; Ansell JS; Schwartz AN
    J Urol; 1987 Sep; 138(3):533-8. PubMed ID: 3625854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accumulation of platelets as a key mechanism of human erection. A scintigraphic study in patients with erectile dysfunction receiving intracavernous injection of PGE1, papaverine/phentolamine.
    Rodrigues M; Granegger S; O'Grady J; Sinzinger H; Stackl W
    Adv Exp Med Biol; 1997; 433():79-82. PubMed ID: 9561108
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence based assessment of erectile dysfunction.
    Broderick GA
    Int J Impot Res; 1998 May; 10 Suppl 2():S64-73; discussion S77-9. PubMed ID: 9647964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamics of papaverine- and phentolamine-induced penile erection.
    Juenemann KP; Lue TF; Fournier GR; Tanagho EA
    J Urol; 1986 Jul; 136(1):158-61. PubMed ID: 3712604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients.
    Fu Q; Yao DH; Jiang YQ
    Asian J Androl; 2000 Dec; 2(4):301-3. PubMed ID: 11202421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the diagnostic value of pump and gravity cavernosometry in the evaluation of the cavernous veno-occlusive mechanism.
    Meuleman EJ; Wijkstra H; Doesburg WH; Debruyne FM
    J Urol; 1991 Nov; 146(5):1266-70. PubMed ID: 1942276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corporeal veno-occlusive dysfunction: predominantly intracavernous muscular pathology.
    Wespes E; Sattar AA; Golzarian J; Wery D; Daoud N; Schulman CC
    J Urol; 1997 May; 157(5):1678-80. PubMed ID: 9112504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of venous leakage: a prospective clinicopathological correlation of corporeal function and structure.
    Nehra A; Goldstein I; Pabby A; Nugent M; Huang YH; de las Morenas A; Krane RJ; Udelson D; Saenz de Tejada I; Moreland RB
    J Urol; 1996 Oct; 156(4):1320-9. PubMed ID: 8808863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal hemodynamic parameters do not always predict the presence of a rigid erection: a quantitative assessment of functional erectile impairment.
    Hatzichristou DG; Hatzimouratidis K; Tzortzis V; Apostolidis A; Bekos A; Ioannidis E
    Int J Impot Res; 2003 Apr; 15(2):99-104. PubMed ID: 12789388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of full nocturnal erections with short duration.
    Montorsi F; Ferini-Strambi L; Guazzoni G; Zucconi M; Smirne S; Rigatti P; Pizzini G; Miani A
    Eur Urol; 1994; 25(1):25-8. PubMed ID: 8307072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Penile flow- and blood pressure index and the effective dose of intracavernous papaverine.
    Van Driel MF; Joosten EA; Mensink HJ
    Acta Urol Belg; 1990; 58(3):39-45. PubMed ID: 2082751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional evaluation of penile arteries with duplex ultrasound in vasodilator-induced erection.
    Lue TF; Mueller SC; Jow YR; Hwang TI
    Urol Clin North Am; 1989 Nov; 16(4):799-807. PubMed ID: 2683308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potassium channels and human corporeal smooth muscle cell tone: diabetes and relaxation of human corpus cavernosum smooth muscle by adenosine triphosphate sensitive potassium channel openers.
    Venkateswarlu K; Giraldi A; Zhao W; Wang HZ; Melman A; Spektor M; Christ GJ
    J Urol; 2002 Jul; 168(1):355-61. PubMed ID: 12050569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of intracorporal pressure and end-diastolic velocity during duplex Doppler sonography in the evaluation of veno-occlusive dysfunction.
    Kropman RF; van Oostayen JA; Zwinderman KH; Lycklama GA; Nijehold A; Schipper J; Meinhardt W
    Int J Impot Res; 1994 Sep; 6(3):125-35. PubMed ID: 7735357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnosis of venogenic impotence: dynamic or pharmacologic cavernosometry?
    Stief CG; Diederichs W; Benard F; Bosch R; Lue TF; Tanagho EA
    J Urol; 1988 Dec; 140(6):1561-3. PubMed ID: 3193543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled trial of infusion cavernosometry in impotent and potent men.
    Lowe MA; Schwartz AN; Berger RE
    J Urol; 1991 Sep; 146(3):783-5. PubMed ID: 1875493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caverno-occlusive and autonomic dysfunction: a new concept in young patients.
    Kayigil ; Ergen A
    Eur Urol; 1998 Aug; 34(2):124-7. PubMed ID: 9693247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cavernosometry: methodology and reproducibility with and without pharmacological agents in the evaluation of venous impotence.
    Kromann-Andersen B; Nielsen KK; Nordling J
    Br J Urol; 1991 May; 67(5):517-21. PubMed ID: 2039921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prostaglandin E1 in erectile dysfunction].
    Porst H
    Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.